BRPI0920355A2 - composições farmacêuticas tópicas estáveis de ozenoxacina e uso de ozenoxacina - Google Patents
composições farmacêuticas tópicas estáveis de ozenoxacina e uso de ozenoxacinaInfo
- Publication number
- BRPI0920355A2 BRPI0920355A2 BRPI0920355A BRPI0920355A BRPI0920355A2 BR PI0920355 A2 BRPI0920355 A2 BR PI0920355A2 BR PI0920355 A BRPI0920355 A BR PI0920355A BR PI0920355 A BRPI0920355 A BR PI0920355A BR PI0920355 A2 BRPI0920355 A2 BR PI0920355A2
- Authority
- BR
- Brazil
- Prior art keywords
- ozenoxacin
- pharmaceutical compositions
- topical pharmaceutical
- stable topical
- stable
- Prior art date
Links
- XPIJWUTXQAGSLK-UHFFFAOYSA-N ozenoxacin Chemical group C1=C(C)C(NC)=NC=C1C1=CC=C2C(=O)C(C(O)=O)=CN(C3CC3)C2=C1C XPIJWUTXQAGSLK-UHFFFAOYSA-N 0.000 title 2
- 229950011011 ozenoxacin Drugs 0.000 title 2
- 239000012049 topical pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08166933A EP2177208A1 (en) | 2008-10-17 | 2008-10-17 | Pharmaceutical topical compositions |
| PCT/EP2009/063625 WO2010043717A2 (en) | 2008-10-17 | 2009-10-16 | Pharmaceutical topical compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0920355A2 true BRPI0920355A2 (pt) | 2016-03-15 |
| BRPI0920355B1 BRPI0920355B1 (pt) | 2020-04-07 |
| BRPI0920355B8 BRPI0920355B8 (pt) | 2021-05-25 |
Family
ID=40291273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0920355A BRPI0920355B8 (pt) | 2008-10-17 | 2009-10-16 | composições farmacêuticas tópicas estáveis de ozenoxacina e uso de ozenoxacina |
Country Status (24)
| Country | Link |
|---|---|
| US (4) | US9180200B2 (pt) |
| EP (3) | EP2177208A1 (pt) |
| JP (2) | JP5509209B2 (pt) |
| KR (3) | KR101682256B1 (pt) |
| CN (1) | CN102186460B (pt) |
| AR (1) | AR073901A1 (pt) |
| AU (1) | AU2009305360B2 (pt) |
| BR (1) | BRPI0920355B8 (pt) |
| CA (2) | CA2822167C (pt) |
| CL (2) | CL2011000848A1 (pt) |
| CY (1) | CY1114838T1 (pt) |
| DK (1) | DK2344130T3 (pt) |
| ES (1) | ES2437967T3 (pt) |
| HK (1) | HK1161552A1 (pt) |
| MX (2) | MX338029B (pt) |
| NL (1) | NL300884I2 (pt) |
| PH (1) | PH12014502425A1 (pt) |
| PL (1) | PL2344130T3 (pt) |
| PT (1) | PT2344130E (pt) |
| RU (1) | RU2478367C2 (pt) |
| SI (1) | SI2344130T1 (pt) |
| TW (2) | TW201511779A (pt) |
| UY (1) | UY32187A (pt) |
| WO (1) | WO2010043717A2 (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2796883A1 (en) * | 2010-05-10 | 2011-11-17 | Segetis, Inc. | Personal care formulations containing alkyl ketal esters and methods of manufacture |
| US9458414B2 (en) | 2012-09-21 | 2016-10-04 | Gfbiochemicals Limited | Cleaning, surfactant, and personal care compositions |
| DE102013226507B4 (de) | 2013-12-18 | 2022-05-05 | Ashland Industries Europe Gmbh | Konzentrat umfassend Ferulasäureethylester und Arylalkanol und dessen Verwendung |
| EP3010511B1 (en) | 2014-09-12 | 2018-02-14 | AntibioTx A/S | Antibacterial use of halogenated salicylanilides |
| JP6775869B2 (ja) * | 2015-02-13 | 2020-10-28 | マルホ株式会社 | ピリドンカルボン酸系誘導体を含有する外用剤 |
| GB201509326D0 (en) | 2015-05-29 | 2015-07-15 | Antibio Tx Aps | Novel use |
| JP7347915B2 (ja) * | 2016-04-28 | 2023-09-20 | マルホ株式会社 | 抗菌剤 |
| WO2018048042A1 (ko) * | 2016-09-12 | 2018-03-15 | 주식회사 가나씨앤에이치 | 글리세린 젖산 에스테르를 유효성분으로 하는 방부 및 항균용 외용제 조성물 |
| JP6504728B2 (ja) * | 2016-12-01 | 2019-04-24 | マルホ株式会社 | 医療用皮膚外用剤 |
| US11419834B2 (en) | 2019-02-25 | 2022-08-23 | Rhode Island Hospital | Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide |
| CN113712913A (zh) * | 2020-05-25 | 2021-11-30 | 南京帝昌医药科技有限公司 | 一种奥泽沙星混悬滴眼液组合物 |
| US11724077B2 (en) * | 2021-07-28 | 2023-08-15 | Subhash Dhawan | Therapeutic swabs for treating upper respiratory infections |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04243827A (ja) * | 1991-01-25 | 1992-08-31 | Sumitomo Pharmaceut Co Ltd | プロスタグランジン誘導体含有溶解型軟膏剤 |
| JP3174590B2 (ja) * | 1991-04-04 | 2001-06-11 | テルモ株式会社 | ステロイド軟膏剤 |
| FR2728166A1 (fr) * | 1994-12-19 | 1996-06-21 | Oreal | Composition topique contenant un antagoniste de substance p |
| JP3162335B2 (ja) * | 1998-03-11 | 2001-04-25 | ユーナイテッド ネイションズ デベロップメント プログラム | 皮膚真菌感染症治療用の植物薬剤、その製造法と用途 |
| DK1070713T3 (da) | 1998-04-06 | 2006-12-27 | Toyama Chemical Co Ltd | Quinoloncarboxylsyrederivater eller salte deraf |
| ATE283700T1 (de) * | 1999-06-08 | 2004-12-15 | Lorantis Ltd | Therapeutische verwendung eines inhibitors des hedgehog signalübertragungsweges |
| JP4293755B2 (ja) | 2001-03-26 | 2009-07-08 | 富山化学工業株式会社 | ピリドンカルボン酸系化合物を含有する皮膚外用剤 |
| JP4384402B2 (ja) | 2001-11-30 | 2009-12-16 | 富山化学工業株式会社 | デスフルオロピリドンカルボン酸系化合物を含有する水溶液剤およびその粉末化物並びにそれら製造方法 |
| DK1731138T3 (en) | 2004-03-31 | 2016-06-06 | Toyama Chemical Co Ltd | Fine dispersion of sparingly soluble drug and the process for preparing the |
| EP1698336A1 (en) * | 2005-03-01 | 2006-09-06 | Ferrer Internacional, S.A. | Antifungal compositions comprising Sertaconazole and either Hydrocortisone or an antibacterial agent |
| CN101272786B (zh) * | 2005-08-01 | 2011-05-04 | 丸宝株式会社 | 含有吡啶酮羧酸衍生物的洗剂 |
| JP5112669B2 (ja) | 2005-09-30 | 2013-01-09 | 富山化学工業株式会社 | 難溶性薬物のナノ微粒子を含有する水性懸濁液剤 |
-
2008
- 2008-10-17 EP EP08166933A patent/EP2177208A1/en not_active Withdrawn
-
2009
- 2009-10-16 KR KR1020117008243A patent/KR101682256B1/ko active IP Right Grant
- 2009-10-16 CN CN2009801408602A patent/CN102186460B/zh active Active
- 2009-10-16 KR KR1020167026446A patent/KR20160116353A/ko not_active Application Discontinuation
- 2009-10-16 BR BRPI0920355A patent/BRPI0920355B8/pt not_active IP Right Cessation
- 2009-10-16 CA CA2822167A patent/CA2822167C/en not_active Expired - Fee Related
- 2009-10-16 RU RU2011119764/15A patent/RU2478367C2/ru active
- 2009-10-16 EP EP09736946.6A patent/EP2344130B9/en active Active
- 2009-10-16 EP EP12192559A patent/EP2570117A1/en not_active Withdrawn
- 2009-10-16 MX MX2013009409A patent/MX338029B/es unknown
- 2009-10-16 CA CA2738384A patent/CA2738384C/en active Active
- 2009-10-16 AU AU2009305360A patent/AU2009305360B2/en not_active Ceased
- 2009-10-16 WO PCT/EP2009/063625 patent/WO2010043717A2/en active Application Filing
- 2009-10-16 ES ES09736946.6T patent/ES2437967T3/es active Active
- 2009-10-16 US US13/124,403 patent/US9180200B2/en active Active
- 2009-10-16 MX MX2011004052A patent/MX2011004052A/es active IP Right Grant
- 2009-10-16 JP JP2011531512A patent/JP5509209B2/ja not_active Expired - Fee Related
- 2009-10-16 DK DK09736946.6T patent/DK2344130T3/da active
- 2009-10-16 KR KR1020167003529A patent/KR20160025034A/ko not_active Application Discontinuation
- 2009-10-16 PT PT97369466T patent/PT2344130E/pt unknown
- 2009-10-16 PL PL09736946T patent/PL2344130T3/pl unknown
- 2009-10-16 SI SI200930749T patent/SI2344130T1/sl unknown
- 2009-10-19 AR ARP090104005A patent/AR073901A1/es unknown
- 2009-10-19 TW TW103134727A patent/TW201511779A/zh unknown
- 2009-10-19 TW TW098135341A patent/TWI504418B/zh not_active IP Right Cessation
- 2009-10-19 UY UY0001032187A patent/UY32187A/es active IP Right Grant
-
2011
- 2011-04-15 CL CL2011000848A patent/CL2011000848A1/es unknown
-
2012
- 2012-02-24 HK HK12101885.2A patent/HK1161552A1/xx not_active IP Right Cessation
-
2013
- 2013-12-03 CY CY20131101082T patent/CY1114838T1/el unknown
-
2014
- 2014-02-21 JP JP2014031852A patent/JP5873120B2/ja not_active Expired - Fee Related
- 2014-03-05 US US14/197,933 patent/US9399014B2/en active Active
- 2014-10-29 PH PH12014502425A patent/PH12014502425A1/en unknown
-
2015
- 2015-09-29 CL CL2015002899A patent/CL2015002899A1/es unknown
- 2015-10-14 US US14/882,818 patent/US20160030338A1/en not_active Abandoned
-
2016
- 2016-05-04 US US15/146,461 patent/US10022363B2/en active Active
-
2017
- 2017-07-11 NL NL300884C patent/NL300884I2/nl unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0920355A2 (pt) | composições farmacêuticas tópicas estáveis de ozenoxacina e uso de ozenoxacina | |
| BRPI0813105A2 (pt) | Derivado de sulfonamida de ácido malônico e uso faramacêutico do mesmo | |
| BR112012013148A2 (pt) | formulação farmacêutica e uso | |
| BR112012002331A2 (pt) | composição antiviral, composição farmacêutica e uso de quantidade efetiva de composição farmacêutica | |
| BRPI0912717A2 (pt) | Composição farmacêutica, e, uso de 5-azacitidina | |
| BRPI0820899A2 (pt) | Formulação cosmética, e, uso da composição | |
| BRPI0913086A2 (pt) | Composições antimicrobianas e métodos de uso | |
| BRPI1011876A2 (pt) | "composição farmacêutica estável e métodos de uso da mesma" | |
| SMT201400181B (it) | Composizioni per vasocostrizione e metodi d'uso | |
| BR112013014231A2 (pt) | composição de higiene pessoal e uso da composição de higiene pessoal | |
| BRPI0921699A2 (pt) | complexo antioxidante, composicoes cosmeticas e farmaceutica contendo o referido complexo e uso deste complexo | |
| BRPI0913726A2 (pt) | rapalogs, composições farmacêuticas, métodos de preparo e uso dos mesmos | |
| BRPI0919942A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| BRPI0907562A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0921375A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0821115A2 (pt) | Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto | |
| BRPI1005292A2 (pt) | composição de decapagem e uso da composição | |
| BRPI0917315A2 (pt) | anticorpo, composicao farmaceutico, e, uso de uma composicao farmaceutica | |
| BRPI1013421A2 (pt) | composição parasticida tópica, e, uso de uma composição | |
| BRPI0908596A2 (pt) | formulação e composição farmacêutica de liberação prolongada | |
| BRPI0813627A2 (pt) | Peptídio antimicrobiano, composições e métodos de uso | |
| BRPI0921879A2 (pt) | composto, composição farmacêutica , e, uso de um composto | |
| BR112013011448A2 (pt) | composto, composição farnmacêutica, e, uso do composto | |
| BRPI0918206A2 (pt) | derivados de animoéster e composição medicinal destes | |
| BRPI0907365A2 (pt) | Composição antimicrobiana e uso |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 07/04/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/10/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 14A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2744 DE 08-08-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |